SRTA
Strata Critical Medical, Inc.
+0.16 (+2.97%)5.38USD138K成交股數476M市值10.8本益比(近四季)1.9股價營收比+60.7%營收年增(近四季)2026-11-09下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 72.5M+102% | 67.4M-874% | 49.3M+37% | 45.1M-34% | 35.9M-30% | −8.7M-112% | 36.1M-41% | 67.9M+50% | 51.5M | 71.4M | 61.0M | 45.3M |
| 營業成本 | 57.3M | 53.3M | 37.7M | 36.1M | 28.9M | −4.3M | 28.6M | 51.6M | 41.4M | 55.9M | 50.6M | 38.1M |
| 毛利 | 15.2M+116% | 14.1M-420% | 11.6M+55% | 9.0M-45% | 7.1M-30% | −4.4M-128% | 7.5M-28% | 16.4M+128% | 10.1M | 15.6M | 10.4M | 7.2M |
| 毛利率 | 21.0% | 21.0% | 23.6% | 20.0% | 19.6% | 50.7% | 20.8% | 24.1% | 19.7% | 21.8% | 17.0% | 15.8% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 14.0M | 15.6M | 16.3M | 13.3M | 12.3M | −5.4M | 13.9M | 25.1M | 17.2M | 19.3M | 18.4M | 16.3M |
| 營業利益 | −5.4M-5% | −3.0M-145% | −5.6M-21% | −4.6M-62% | −5.7M-42% | 6.6M-188% | −7.1M-42% | −12.1M-5% | −9.9M | −7.4M | −12.2M | −12.8M |
| 營業利益率 | -7.5% | -4.4% | -11.4% | -10.3% | -15.8% | -75.6% | -19.7% | -17.9% | -19.2% | -10.4% | -20.0% | -28.3% |
| 稅後淨利 | −10.5M+201% | 2.2M-122% | 57.4M-3038% | −3.7M-67% | −3.5M-18% | −9.8M-3489% | −2.0M-84% | −11.3M+11% | −4.2M | 289K | −12.2M | −10.2M |
| 淨利率 | -14.5% | 3.2% | 116.5% | -8.3% | -9.7% | 112.5% | -5.4% | -16.7% | -8.2% | 0.4% | -20.1% | -22.5% |
| 稀釋 EPS | -0.12+200% | 0.03-127% | 0.70-2433% | -0.05-67% | -0.04-33% | -0.11 | -0.03-82% | -0.15+7% | -0.06 | 0.00 | -0.17 | -0.14 |
| 稀釋股數 | 86.2M | 90.2M | 82.5M | 81.3M | 79.9M | 77.5M | 78.0M | 77.6M | 75.8M | 81.0M | 73.2M | 72.0M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 16.3M | 58.7M | 22.8M | 58.8M | 34.8M | 18.4M | 20.0M | 26.3M | 36.8M | 36.8M | 37.3M | 41.7M |
| 應收帳款 | 43.4M | 39.6M | 37.5M | 28.2M | 22.1M | 19.8M | 24.5M | 27.7M | 23.6M | 21.0M | 22.5M | 16.5M |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 333M | 328M | 335M | 258M | 251M | 257M | 283M | 280M | 283M | 318M | 320M | 322M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 53.4M | 41.9M | 52.1M | 34.8M | 30.8M | 34.7M | 49.4M | 50.9M | 46.2M | 54.6M | 59.4M | 52.2M |
| 股東權益 | 279M | 286M | 283M | 223M | 220M | 222M | 233M | 229M | 237M | 263M | 261M | 270M |
| 負債比 | 16.0% | 12.8% | 15.5% | 13.5% | 12.3% | 13.5% | 17.5% | 18.2% | 16.3% | 17.2% | 18.6% | 16.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | 3.9M | – | – | −246K-98% | – | – | – | −15.6M | – | – | −16.9M |
| 資本支出 | – | 5.2M | – | – | 2.6M | – | – | – | 816K | – | – | 646K |
| 自由現金流 | – | −1.3M | – | – | −2.9M-83% | – | – | – | −16.4M | – | – | −17.5M |
| 折舊攤銷 | – | 3.1M | – | 1.8M | 1.7M | 1.5M | 1.3M | 1.6M | 1.6M | 1.8M | 1.8M | 1.7M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -1.9% | – | – | -8.0% | – | – | – | -31.8% | – | – | -38.7% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2025 年度 · 197M
| Logistics | 177M | 89.7% | +20.4% |
|---|---|---|---|
| Clinical | 20.3M | 10.3% | – |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 197M | +34.3% | 41.3M | 21.0% | 0.50 | −58.5M |
| FY2024 | 147M | -34.8% | −27.3M | -18.6% | -0.35 | −33.4M |
| FY2023 | 225M | +54.1% | −56.1M | -24.9% | -0.76 | −34.5M |
| FY2022 | 146M | +189.2% | −27.3M | -18.7% | -0.38 | −37.9M |
| FY2021 | 50.5M | – | −40.1M | -79.3% | -0.93 | −15.9M |
| FY2020 | – | – | −20.5M | –% | -2.17 | – |
| FY2020 | 23.4M | – | −10.2M | -43.4% | -0.40 | −11.2M |
| FY2019 | – | – | 2.3M | –% | 0.19 | – |